| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |